Gene hunt aims to prevent SSRI agitation in children

NCT ID NCT06763081

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study is looking for genetic markers linked to a side effect called behavioral activation—feeling overly excited or agitated—that can happen when children and youth take SSRI antidepressants for depression, anxiety, or OCD. Researchers will collect DNA from 160 participants aged 6 to 24 in Manitoba and compare those who had the side effect to those who didn't. The goal is to find a set of genes that could one day help doctors choose safer medications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could help doctors predict which kids might have bad side effects from common antidepressants, making treatment safer.
What could go wrong
This is an observational study, not a treatment trial. It may not find clear genetic markers, and results might not change practice for years.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTIDEPRESSANT DRUG ADVERSE REACTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Shared Health Facilities

    RECRUITING

    Winnipeg, Manitoba, R3C 3H8, Canada

  • University of Manitoba College of Pharmacy

    RECRUITING

    Winnipeg, Manitoba, R3E 0T5, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.